Abstract:
본 발명은, 생리학적 허용가능 매질 내에 폴리올레핀에서 유도된 하나 이상의 올리고머 또는 중합체를 유화제로서 함유하는 유중수 에멀션에 관한 것이다. 사용되는 올리고머 또는 중합체는 바람직하게는 임의로 에스테르화되거나 아미드화된 숙신 말단부를 갖는 폴리올레핀, 또는 상기 폴리올레핀의 염, 특히 에스테르화 또는 아미드화 숙신 말단부를 갖는 폴리이소부틸렌이다. 수득된 에멀션은 높은 비율의 수성상의 존재 하에서도 안정하다. 또한, 이것은 적용시 신선한 느낌을 제공한다. 이것은 특히 화장용, 피부과적 및 약학적 분야, 특히 피부 및/또는 네일 케어용, 피부의 메이크업 제거 및/또는 클렌싱용, 및/또는 피부 메이크업으로서 사용될 수 있다.
Abstract:
Composition comprising an aqueous phase dispersed in an oil phase includes an emulsifier comprising a polar portion and a nonpolar polyolefin portion of at least 40 carbon atoms.
Abstract:
An oil-in-water nanoemulsion (A) with oil globule size below 100 nm comprising at least one amphiphilic non-ionic or anionic lipid and at least one non-ionic hydrosoluble polymer has a weight ratio of oily phase to amphiphilic lipid of 1.2-10. An oil-in-water nanoemulsion (A) with oil globule size below 100 nm comprising at least one amphiphilic non-ionic or anionic lipid and at least one nonionic hydrosoluble polymer (B) has a weight ratio of oily phase to amphiphilic lipid of 1.2-10. (B) is homo- and copolymers of ethylene oxide, of vinylalcohols, of vinylpyrrolidone, of vinylcaprolactam, or of vinylmethylether; homo- and copolymers of neutral acrylics; (1-2C)alkylcelluloses and their derivatives; or (hydroxy)(1-3C)alkylguar. Independent claims are also included for: (1) a cosmetic or dermatological composition comprising (A); (2) an ophthalmic support containing (A); (3) a pharmaceutical composition containing (A); and (4) a process of thickening a nanoemulsion with the hydrosoluble polymers above.
Abstract:
PURPOSE: Provided is an oil-in-water nanoemulsion including an oily phase which is dispersed in an aqueous phase and includes oil globules having a number-average size of less than 100nm. Therefore, the nanoemulsion obtained is preferably transparent and stable on storage and may form a composition for topical, preferably cosmetic or dermatological compositions, pharmaceutical compositions and ophthalmological compositions. CONSTITUTION: This nanoemulsion comprises: (i) at least one amphiphilic lipid selected from the group including nonionic amphiphilic lipids and anionic amphiphilic lipids; and (ii) at least one water-soluble nonionic polymer selected from the group including homopolymers and copolymers of ethylene oxide; polyvinyl alcohols; homopolymers and copolymers of vinylpyrrolidone; homopolymers and copolymers of vinylcaprolactam; homopolymers and copolymers of polyvinyl methyl ether; neutral acrylic homopolymers and copolymers; C1-2 alkyl celluloses and their derivatives; C1-3 alkyl guar; C1-3 hydroxyalkyl guar, wherein the weight ratio of the oily phase to the amphiphilic lipid is 1.2 to 10.